Back to Search
SAM PENZA, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1356359640IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35061774(OH)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
35061774(OH)
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1989
Research & Publications (19)
Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia.
PMID 19539217·Biol Blood Marrow Transplant·2009
3-trial
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.
PMID 18541197·Biol Blood Marrow Transplant·2008
3-trial
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma.
PMID 17070906·Leuk Res·2007
8-other
Effects of a walking aid in COPD patients receiving oxygen therapy.
PMID 17426211·Chest·2007
4-observational
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
PMID 17162217·Biol Blood Marrow Transplant·2006
8-other
High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.
PMID 16399569·Biol Blood Marrow Transplant·2006
4-observational
Syngeneic vs. allotransplantation in chronic myeloid leukemia: all's well that ends well.
PMID 16082344·Transplantation·2005
5-case
Diffuse alveolar hemorrhage following gemtuzumab ozogamicin.
PMID 15735659·Bone Marrow Transplant·2005
5-case
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia.
PMID 15711571·Bone Marrow Transplant·2005
3-trial
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.
PMID 15156164·Bone Marrow Transplant·2004
3-trial
Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults with low-risk disease.
PMID 12621488·Bone Marrow Transplant·2003
4-observational
Second autologous stem cell transplant for multiply relapsed Hodgkin's disease.
PMID 12040474·Bone Marrow Transplant·2002
8-other
Oral precancerous and malignant lesions associated with graft-versus-host disease: report of 2 cases.
PMID 11805779·Oral Surg Oral Med Oral Pathol Oral Radiol Endod·2002
5-case
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation.
PMID 11786567·J Clin Oncol·2002
3-trial
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation.
PMID 11551021·Bone Marrow Transplant·2001
8-other
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy.
PMID 11108300·Bone Marrow Transplant·2000
8-other
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma.
PMID 10871728·Bone Marrow Transplant·2000
3-trial
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation.
PMID 10871724·Bone Marrow Transplant·2000
3-trial
Emotion management skills in sexually maltreated and nonmaltreated girls: a developmental psychopathology perspective.
PMID 10774595·Dev Psychopathol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 460 W 10TH AVE FL 5
COLUMBUS, OH 43210 - Phone
- (614) 293-3196
Quick Facts
- NPI
- 1356359640
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 37
- Publications
- 19
Are you this provider?
Claim Your Profile